1. Home
  2. CODX vs VRAR Comparison

CODX vs VRAR Comparison

Compare CODX & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Co-Diagnostics Inc.

CODX

Co-Diagnostics Inc.

HOLD

Current Price

$0.18

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Logo The Glimpse Group Inc.

VRAR

The Glimpse Group Inc.

HOLD

Current Price

$0.87

Market Cap

17.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CODX
VRAR
Founded
2013
2016
Country
United States
United States
Employees
N/A
40
Industry
Medical/Dental Instruments
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
17.2M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
CODX
VRAR
Price
$0.18
$0.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$2.25
$2.62
AVG Volume (30 Days)
1.6M
129.7K
Earning Date
11-13-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,892.00
$9,488,209.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18.89
$72.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.60
52 Week Low
$0.22
$0.77
52 Week High
$1.55
$3.14

Technical Indicators

Market Signals
Indicator
CODX
VRAR
Relative Strength Index (RSI) 30.03 36.26
Support Level $0.22 $0.77
Resistance Level $0.30 $0.88
Average True Range (ATR) 0.03 0.09
MACD -0.01 -0.00
Stochastic Oscillator 2.05 21.49

Price Performance

Historical Comparison
CODX
VRAR

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

Share on Social Networks: